ID ODO2_MOUSE Reviewed; 454 AA. AC Q9D2G2; Q3UEA0; Q4FK55; Q8CIE8; DT 12-APR-2005, integrated into UniProtKB/Swiss-Prot. DT 01-JUN-2001, sequence version 1. DT 24-JAN-2024, entry version 177. DE RecName: Full=Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial {ECO:0000305}; DE EC=2.3.1.61 {ECO:0000250|UniProtKB:P36957}; DE AltName: Full=2-oxoglutarate dehydrogenase complex component E2; DE Short=OGDC-E2; DE AltName: Full=Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex; DE AltName: Full=E2K; DE Flags: Precursor; GN Name=Dlst {ECO:0000312|MGI:MGI:1926170}; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC STRAIN=C57BL/6J, and NOD; RC TISSUE=Bone marrow, Heart, Oviduct, Testis, and Visual cortex; RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J., RA Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R., RA Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T., RA Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A., RA Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., RA Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M., RA Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S., RA Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D., RA Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M., RA Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H., RA Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V., RA Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S., RA Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H., RA Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N., RA Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F., RA Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., RA Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., RA Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S., RA Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K., RA Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R., RA van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H., RA Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M., RA Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C., RA Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S., RA Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K., RA Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M., RA Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C., RA Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A., RA Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RA Ebert L., Muenstermann E., Schatten R., Henze S., Bohn E., Mollenhauer J., RA Wiemann S., Schick M., Korn B.; RT "Cloning of mouse full open reading frames in Gateway(R) system entry RT vector (pDONR201)."; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). RC STRAIN=Czech II, and FVB/N; TISSUE=Mammary tumor; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP PROTEIN SEQUENCE OF 69-89; 288-308; 314-334 AND 355-346, AND IDENTIFICATION RP BY MASS SPECTROMETRY. RC STRAIN=OF1; TISSUE=Hippocampus; RA Lubec G., Klug S., Sunyer B., Chen W.-Q.; RL Submitted (JAN-2009) to UniProtKB. RN [5] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung, RC Pancreas, Spleen, and Testis; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). RN [6] RP ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-155; LYS-268; LYS-273; LYS-274; RP LYS-278 AND LYS-308, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE RP ANALYSIS]. RC TISSUE=Liver; RX PubMed=23576753; DOI=10.1073/pnas.1302961110; RA Rardin M.J., Newman J.C., Held J.M., Cusack M.P., Sorensen D.J., Li B., RA Schilling B., Mooney S.D., Kahn C.R., Verdin E., Gibson B.W.; RT "Label-free quantitative proteomics of the lysine acetylome in mitochondria RT identifies substrates of SIRT3 in metabolic pathways."; RL Proc. Natl. Acad. Sci. U.S.A. 110:6601-6606(2013). RN [7] RP SUBCELLULAR LOCATION, AND SUBUNIT. RX PubMed=36854377; DOI=10.1098/rsob.220363; RA Hevler J.F., Albanese P., Cabrera-Orefice A., Potter A., Jankevics A., RA Misic J., Scheltema R.A., Brandt U., Arnold S., Heck A.J.R.; RT "MRPS36 provides a structural link in the eukaryotic 2-oxoglutarate RT dehydrogenase complex."; RL Open Biol. 13:220363-220363(2023). CC -!- FUNCTION: Dihydrolipoamide succinyltransferase (E2) component of the 2- CC oxoglutarate dehydrogenase complex (By similarity). The 2-oxoglutarate CC dehydrogenase complex catalyzes the overall conversion of 2- CC oxoglutarate to succinyl-CoA and CO(2) (By similarity). The 2- CC oxoglutarate dehydrogenase complex is mainly active in the CC mitochondrion. A fraction of the 2-oxoglutarate dehydrogenase complex CC also localizes in the nucleus and is required for lysine succinylation CC of histones: associates with KAT2A on chromatin and provides succinyl- CC CoA to histone succinyltransferase KAT2A (By similarity). CC {ECO:0000250|UniProtKB:P36957, ECO:0000250|UniProtKB:Q9N0F1}. CC -!- CATALYTIC ACTIVITY: CC Reaction=N(6)-[(R)-dihydrolipoyl]-L-lysyl-[2-oxoglutarate dehydrogenase CC complex component E2] + succinyl-CoA = CoA + N(6)-[(R)-S(8)- CC succinyldihydrolipoyl]-L-lysyl-[2-oxoglutarate dehydrogenase complex CC component E2]; Xref=Rhea:RHEA:15213, Rhea:RHEA-COMP:10581, Rhea:RHEA- CC COMP:10582, ChEBI:CHEBI:57287, ChEBI:CHEBI:57292, ChEBI:CHEBI:83100, CC ChEBI:CHEBI:83120; EC=2.3.1.61; CC Evidence={ECO:0000250|UniProtKB:P36957}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:15215; CC Evidence={ECO:0000250|UniProtKB:P36957}; CC -!- COFACTOR: CC Name=(R)-lipoate; Xref=ChEBI:CHEBI:83088; CC Evidence={ECO:0000250|UniProtKB:P11179}; CC Note=Binds 1 lipoyl cofactor covalently. CC {ECO:0000250|UniProtKB:P11179}; CC -!- PATHWAY: Amino-acid degradation; L-lysine degradation via saccharopine CC pathway; glutaryl-CoA from L-lysine: step 6/6. CC -!- PATHWAY: Carbohydrate metabolism; tricarboxylic acid cycle. CC {ECO:0000250|UniProtKB:P36957}. CC -!- SUBUNIT: The 2-oxoglutarate dehydrogenase complex is composed of OGDH CC (2-oxoglutarate dehydrogenase; E1), DLST (dihydrolipoamide CC succinyltransferase; E2), DLD (dihydrolipoamide dehydrogenase; E3) and CC the assembly factor KGD4 (PubMed:36854377). It contains multiple copies CC of the three enzymatic components (E1, E2 and E3). In the nucleus, the CC 2-oxoglutarate dehydrogenase complex associates with KAT2A. Interacts CC with ABHD11; this interaction maintains the functional lipoylation of CC the 2-oxoglutarate dehydrogenase complex (By similarity). CC {ECO:0000250|UniProtKB:P36957, ECO:0000269|PubMed:36854377}. CC -!- INTERACTION: CC Q9D2G2; Q9QXS1: Plec; NbExp=2; IntAct=EBI-773210, EBI-774583; CC -!- SUBCELLULAR LOCATION: Mitochondrion matrix CC {ECO:0000250|UniProtKB:P36957}. Nucleus {ECO:0000250|UniProtKB:P36957}. CC Note=Mainly localizes in the mitochondrion. A small fraction localizes CC to the nucleus, where the 2-oxoglutarate dehydrogenase complex is CC required for histone succinylation. {ECO:0000250|UniProtKB:P36957}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q9D2G2-1; Sequence=Displayed; CC Name=2; CC IsoId=Q9D2G2-2; Sequence=VSP_025015, VSP_025016; CC -!- SIMILARITY: Belongs to the 2-oxoacid dehydrogenase family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AK019713; BAB31840.1; -; mRNA. DR EMBL; AK054053; BAC35637.1; -; mRNA. DR EMBL; AK149664; BAE29011.1; -; mRNA. DR EMBL; AK158877; BAE34709.1; -; mRNA. DR EMBL; AK168570; BAE40440.1; -; mRNA. DR EMBL; AK169943; BAE41472.1; -; mRNA. DR EMBL; CT010197; CAJ18405.1; -; mRNA. DR EMBL; BC006702; AAH06702.1; -; mRNA. DR EMBL; BC024066; AAH24066.1; -; mRNA. DR CCDS; CCDS26052.1; -. [Q9D2G2-1] DR RefSeq; NP_084501.1; NM_030225.4. [Q9D2G2-1] DR AlphaFoldDB; Q9D2G2; -. DR SMR; Q9D2G2; -. DR BioGRID; 219707; 35. DR IntAct; Q9D2G2; 62. DR MINT; Q9D2G2; -. DR STRING; 10090.ENSMUSP00000060346; -. DR ChEMBL; CHEMBL2176822; -. DR GlyGen; Q9D2G2; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; Q9D2G2; -. DR MetOSite; Q9D2G2; -. DR PhosphoSitePlus; Q9D2G2; -. DR SwissPalm; Q9D2G2; -. DR REPRODUCTION-2DPAGE; Q9D2G2; -. DR EPD; Q9D2G2; -. DR jPOST; Q9D2G2; -. DR MaxQB; Q9D2G2; -. DR PaxDb; 10090-ENSMUSP00000060346; -. DR PeptideAtlas; Q9D2G2; -. DR ProteomicsDB; 293493; -. [Q9D2G2-1] DR ProteomicsDB; 293494; -. [Q9D2G2-2] DR Pumba; Q9D2G2; -. DR TopDownProteomics; Q9D2G2-1; -. [Q9D2G2-1] DR TopDownProteomics; Q9D2G2-2; -. [Q9D2G2-2] DR Antibodypedia; 45; 224 antibodies from 29 providers. DR DNASU; 78920; -. DR Ensembl; ENSMUST00000053811.10; ENSMUSP00000060346.9; ENSMUSG00000004789.11. [Q9D2G2-1] DR Ensembl; ENSMUST00000221357.2; ENSMUSP00000152664.2; ENSMUSG00000004789.11. [Q9D2G2-1] DR GeneID; 78920; -. DR KEGG; mmu:78920; -. DR UCSC; uc007ogj.2; mouse. [Q9D2G2-1] DR AGR; MGI:1926170; -. DR CTD; 1743; -. DR MGI; MGI:1926170; Dlst. DR VEuPathDB; HostDB:ENSMUSG00000004789; -. DR eggNOG; KOG0559; Eukaryota. DR GeneTree; ENSGT00930000151014; -. DR HOGENOM; CLU_016733_0_0_1; -. DR InParanoid; Q9D2G2; -. DR OMA; MKVPSPG; -. DR OrthoDB; 672at2759; -. DR PhylomeDB; Q9D2G2; -. DR TreeFam; TF314164; -. DR BRENDA; 2.3.1.61; 3474. DR Reactome; R-MMU-389661; Glyoxylate metabolism and glycine degradation. DR Reactome; R-MMU-71064; Lysine catabolism. DR Reactome; R-MMU-71403; Citric acid cycle (TCA cycle). DR UniPathway; UPA00223; -. DR UniPathway; UPA00868; UER00840. DR BioGRID-ORCS; 78920; 26 hits in 83 CRISPR screens. DR ChiTaRS; Dlst; mouse. DR PRO; PR:Q9D2G2; -. DR Proteomes; UP000000589; Chromosome 12. DR RNAct; Q9D2G2; Protein. DR Bgee; ENSMUSG00000004789; Expressed in heart right ventricle and 302 other cell types or tissues. DR ExpressionAtlas; Q9D2G2; baseline and differential. DR GO; GO:0005829; C:cytosol; ISO:MGI. DR GO; GO:0005759; C:mitochondrial matrix; IEA:UniProtKB-SubCell. DR GO; GO:0005739; C:mitochondrion; HDA:MGI. DR GO; GO:0043209; C:myelin sheath; HDA:UniProtKB. DR GO; GO:0005654; C:nucleoplasm; ISO:MGI. DR GO; GO:0005634; C:nucleus; ISS:UniProtKB. DR GO; GO:0045252; C:oxoglutarate dehydrogenase complex; IMP:MGI. DR GO; GO:0016746; F:acyltransferase activity; ISS:UniProtKB. DR GO; GO:0004149; F:dihydrolipoyllysine-residue succinyltransferase activity; ISS:UniProtKB. DR GO; GO:0031072; F:heat shock protein binding; ISO:MGI. DR GO; GO:0051087; F:protein-folding chaperone binding; ISO:MGI. DR GO; GO:0006103; P:2-oxoglutarate metabolic process; ISS:UniProtKB. DR GO; GO:0106077; P:histone succinylation; ISS:UniProtKB. DR GO; GO:0033512; P:L-lysine catabolic process to acetyl-CoA via saccharopine; IEA:UniProtKB-UniPathway. DR GO; GO:0006734; P:NADH metabolic process; ISO:MGI. DR GO; GO:0006104; P:succinyl-CoA metabolic process; ISS:UniProtKB. DR GO; GO:0006099; P:tricarboxylic acid cycle; ISS:UniProtKB. DR CDD; cd06849; lipoyl_domain; 1. DR Gene3D; 2.40.50.100; -; 1. DR Gene3D; 3.30.559.10; Chloramphenicol acetyltransferase-like domain; 1. DR InterPro; IPR003016; 2-oxoA_DH_lipoyl-BS. DR InterPro; IPR001078; 2-oxoacid_DH_actylTfrase. DR InterPro; IPR000089; Biotin_lipoyl. DR InterPro; IPR023213; CAT-like_dom_sf. DR InterPro; IPR011053; Single_hybrid_motif. DR InterPro; IPR006255; SucB. DR NCBIfam; TIGR01347; sucB; 1. DR PANTHER; PTHR43416:SF5; DIHYDROLIPOYLLYSINE-RESIDUE SUCCINYLTRANSFERASE COMPONENT OF 2-OXOGLUTARATE DEHYDROGENASE COMPLEX, MITOCHONDRIAL; 1. DR PANTHER; PTHR43416; DIHYDROLIPOYLLYSINE-RESIDUE SUCCINYLTRANSFERASE COMPONENT OF 2-OXOGLUTARATE DEHYDROGENASE COMPLEX, MITOCHONDRIAL-RELATED; 1. DR Pfam; PF00198; 2-oxoacid_dh; 1. DR Pfam; PF00364; Biotin_lipoyl; 1. DR SUPFAM; SSF52777; CoA-dependent acyltransferases; 1. DR SUPFAM; SSF51230; Single hybrid motif; 1. DR PROSITE; PS50968; BIOTINYL_LIPOYL; 1. DR PROSITE; PS00189; LIPOYL; 1. DR UCD-2DPAGE; Q9D2G2; -. DR Genevisible; Q9D2G2; MM. PE 1: Evidence at protein level; KW Acetylation; Acyltransferase; Alternative splicing; KW Direct protein sequencing; Lipoyl; Mitochondrion; Nucleus; Phosphoprotein; KW Reference proteome; Transferase; Transit peptide; Tricarboxylic acid cycle. FT TRANSIT 1..68 FT /note="Mitochondrion" FT /evidence="ECO:0000250" FT CHAIN 69..454 FT /note="Dihydrolipoyllysine-residue succinyltransferase FT component of 2-oxoglutarate dehydrogenase complex, FT mitochondrial" FT /id="PRO_0000020473" FT DOMAIN 71..145 FT /note="Lipoyl-binding" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01066" FT REGION 147..227 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 167..198 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 425 FT /evidence="ECO:0000250|UniProtKB:Q9N0F1" FT ACT_SITE 429 FT /evidence="ECO:0000250|UniProtKB:Q9N0F1" FT MOD_RES 82 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 111 FT /note="N6-lipoyllysine" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01066" FT MOD_RES 155 FT /note="N6-acetyllysine" FT /evidence="ECO:0007744|PubMed:23576753" FT MOD_RES 268 FT /note="N6-acetyllysine" FT /evidence="ECO:0007744|PubMed:23576753" FT MOD_RES 273 FT /note="N6-acetyllysine" FT /evidence="ECO:0007744|PubMed:23576753" FT MOD_RES 274 FT /note="N6-acetyllysine" FT /evidence="ECO:0007744|PubMed:23576753" FT MOD_RES 278 FT /note="N6-acetyllysine" FT /evidence="ECO:0007744|PubMed:23576753" FT MOD_RES 308 FT /note="N6-acetyllysine" FT /evidence="ECO:0007744|PubMed:23576753" FT VAR_SEQ 1..253 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_025015" FT VAR_SEQ 254..257 FT /note="EVDM -> MTSL (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_025016" FT CONFLICT 276 FT /note="N -> S (in Ref. 1; BAE29011)" FT /evidence="ECO:0000305" SQ SEQUENCE 454 AA; 48995 MW; 9CB31698D185442A CRC64; MLSRSRCVSR AFSRSLSAFQ KGNCPLGRRS LPGVSLCRGP GYPDNRKMVI NSGSVFRVRF FQTTAVCKND VITVQTPAFA ESVTEGDVRW EKAVGDAVAE DEVVCEIETD KTSVQVPSPA NGIIEALLVP DGGKVEGGTP LFTLRKTGAA PAKAKPAETP APAHKAEPAA PAAPPPPAAP VLTQMPPVPS PSQPPSSKPV SAIKPTAAPP LAEAGAAKGL RSEHREKMNR MRQRIAQRLK EAQNTCAMLT TFNEVDMSNI QEMRARHKDA FLKKHNLKLG FMSAFVKASA FALQEQPVVN AVIDDATKEV VYRDYIDISV AVATPRGLVV PVIRNVETMN YADIERTINE LGEKARKNEL AIEDMDGGTF TISNGGVFGS LFGTPIINPP QSAILGMHAI FDRPVAVGGK VEVRPMMYVA LTYDHRLIDG REAVTFLRKI KAAVEDPRVL LLDL //